Condition: Diabetic Foot Ulcer · Diabetic Foot Infection · Sponsor: Nanordica Medical OU
This clinical trial evaluates the safety and efficacy of the Nanordica Advanced Antibacterial Wound Dressing (AAWD) in patients suffering from diabetic foot ulcers. At least 170 participants will be randomly allocated to be treated either with AAWD or Aquacel Ag+ Extra wound dressing for a 4-week active phase (intervention) followed by an 8-week standard of care period.
This description comes directly from the study's public registry record.
Grigory Vasiliev · +372 5345 2230 · grigory@nanordica.com
Always discuss trial participation with your own doctor first.
| East Tallinn Central Hospital | Tallinn, Harju, Estonia | Recruiting |
| North Estonia Medical Centre Foundation | Tallinn, Harju, Estonia | Recruiting |
| Tartu University Hospital | Tartu, Tartu, Estonia | Recruiting |
| Centro de Salud de Arcos de la Frontera | Arcos de la Frontera, Cádiz, Spain | Recruiting |
| Hospital Puerta del Mar | Cadiz, Cádiz, Spain | Recruiting |
| Centro de Salud San Benito | Jerez de la Frontera, Cádiz, Spain | Recruiting |
| Hospital de León | León, León, Spain | Recruiting |
| Clínica Universitaria de Podología de la Universidad Complutense de Madrid | Madrid, Madrid, Spain | Recruiting |
| Hospital Ramón y Cajal | Madrid, Spain | Recruiting |
| Hospital Universitario Fundación Alcorcón | Madrid, Spain | Recruiting |
| Hospital Universitario de Donostia | San Sebastián, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06667752